Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | CARM1 | Q86X55 | 2/20 | 0.56 |
| ▸ | PRMT6 | Q96LA8 | 2/20 | 0.56 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.56 |
| ▸ | PRMT8 | Q9NR22 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 3/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.47 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.44 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.42 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.42 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7220231 | 0.98 | ALOX15 (0.55) | ALOX15CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL20366986 | 0.91 | CARM1 (0.48) | ALOX15CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL24951491 | 0.86 | — | — | |
| SCHEMBL14197772 | 0.86 | — | — | |
| SCHEMBL18781684 | 0.86 | — | — | |
| SCHEMBL1290862 | 0.86 | CARM1 (0.52) | CARM1PRMT6PRMT1PRMT8POLB | |
| SCHEMBL25031743 | 0.84 | SIGMAR1 (0.50) | CARM1PRMT6PRMT1PRMT8POLB | |
| SCHEMBL20234635 | 0.84 | CARM1 (0.65) | CARM1PRMT6PRMT1PRMT8POLB | |
| SCHEMBL30786293 | 0.82 | SIGMAR1 (0.53) | CARM1PRMT6PRMT1PRMT8POLB | |
| Trifluoroacetic Acid SCHEMBL4010460 | 0.82 | POLB (0.49) | ALOX15CARM1PRMT6PRMT1PRMT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4457258-A1 | POLYOL CATALYST FOR A TWO-COMPONENT POLYURETHANE SYSTEM | ARKEMA FRANCE (FR) | 2024-11-06 | — | — | EP | claimed |
| CN-118488982-A | Polyol catalyst for two-component polyurethane systems | 阿科玛法国公司 | 2024-08-13 | — | — | CN | claimed |
| WO-2023126199-A1 | POLYOL CATALYST FOR A TWO-COMPONENT POLYURETHANE SYSTEM | ARKEMA FRANCE (FR) | 2023-07-06 | — | — | WO | claimed |
| EP-1633348-B1 | 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | ELAN PHARM INC (US) | 2008-10-08 | — | — | EP | claimed |
| US-7432379-B2 | Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | ELAN PHARMACEUTICALS, INC. (US) | 2008-10-07 | — | — | US | claimed |
| EP-1633348-A1 | 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | Elan Pharmaceuticals, Inc. (US) | 2006-03-15 | — | — | EP | claimed |
| US-20050020659-A1 | Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | ELAN PHARMACEUTICALS, INC. | 2005-01-27 | — | — | US | claimed |
| WO-2004098589-A1 | 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | ELAN PHARMACEUTICALS, INC. (US) | 2004-11-18 | — | — | WO | claimed |
| EP-0765865-B1 | 2-ACYLAMINOPROPANOL COMPOUND AND MEDICINAL COMPOSITION | SEIKAGAKU KOGYO CO LTD (JP) | 2001-12-12 | — | — | EP | claimed |
| US-5763438-A | ANTIVIRAL AGENTS | SEIKAGAKU CORPORATION (JP) | 1998-06-09 | — | — | US | claimed |
| EP-0765865-A1 | 2-ACYLAMINOPROPANOL COMPOUND AND MEDICINAL COMPOSITION | SEIKAGAKU CORPORATION (JP) | 1997-04-02 | — | — | EP | claimed |
| JP-63301297-A | — | — | None | — | — | JP | disclosed |
| US-12528948-B2 | Amino (meth)acrylates | ALLNEX BELGIUM S.A. (BE) | 2026-01-20 | — | — | US | disclosed |
| WO-2025053634-A1 | NOVEL QUINAZOLINE-BENZIMIDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND USE THEREOF | 고려대학교 산학협력단 | 2025-03-13 | — | — | WO | disclosed |
| EP-4457258-A1 | POLYOL CATALYST FOR A TWO-COMPONENT POLYURETHANE SYSTEM | ARKEMA FRANCE (FR) | 2024-11-06 | — | — | EP | disclosed |
| EP-0387381-A1 | Process for producing unsaturated dicarboxylic acid imide compound | MATSUSHITA ELECTRIC WORKS, LTD. (JP) | 1990-09-19 | — | — | EP | disclosed |
| JP-S63301297-A | METAL ROLLING OIL COMPOSITION | DAIDO KAGAKU KOGYO KK | 1988-12-08 | — | — | JP | disclosed |
| EP-0104506-B1 | 6-((CYCLIC AMINO)ALKYLAMINO)TETRAHYDROTRIAZOLO(3,4-A)PHTHALAZINES | THE DOW CHEMICAL COMPANY (US) | 1986-11-05 | — | — | EP | disclosed |
| US-4487930-A | 6-[(Cyclic amino)alkylamino]-tetrahydrotriazolo[3,4-a]phthalazines | THE DOW CHEMICAL COMPANY (US) | 1984-12-11 | — | — | US | disclosed |
| EP-0104506-A1 | 6-((Cyclic amino)alkylamino)tetrahydrotriazolo(3,4-a)phthalazines | THE DOW CHEMICAL COMPANY (US) | 1984-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020659-A1 | Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | BDKRB1, BDKRB2, BRS3 | ALOX15 1190/4885CARM1 4625/4885PRMT6 3826/4885 |
| US-12528948-B2 | Amino (meth)acrylates | MAT2B, MAT1A, MMAB | ALOX15 3780/4885CARM1 134/4885PRMT6 652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.